Venous thromboembolism pharmacologic prophylaxis after major surgery-are we doing well or not well enough?

Annals of Surgery

Volumn 253, Issue 2, 2011, Pages 221-222

  Kakkar, Ajay K ^a   Rushton Smith, Sophie ^a  

^a THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; BLEEDING; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HIGH RISK PATIENT; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; HYSTERECTOMY; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR SURGERY; MORBIDITY; MORTALITY; PHYSICIAN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; SURGICAL PATIENT; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; HOSPITAL MORTALITY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; QUALITY ASSURANCE, HEALTH CARE; SURGICAL PROCEDURES, ELECTIVE; VENOUS THROMBOEMBOLISM;

EID: 79151479858     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318208f427     Document Type: Editorial

References (35)

1. Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ. 1991;302(6778):709-711.
2. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med. 1989;82(4):203-205.
3. Alikhan R, Peters F,Wilmott R, et al. Fatal pulmonary embolism in hospitalised patients: a necropsy review. J Clin Pathol 2004; 57(12):1254-1257.
4. Anderson FA Jr, Zayaruzny M, Heit JA, et al. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol. 2007;82(9):777-782.
5. Park B, Messina L, Dargon P, et al. Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample. Chest. 2009;136(4):983-990.
6. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA. 2003;290(14):1868-1874.
7. Kakkar VV, Field ES, Nicolaides AN. Prevention of postoperative deep-vein thrombosis using heparin. Br J Surg. 1971;58(11):872-873.
8. Kakkar VV, Field ES, Nicolaides AN, et al. Low doses of heparin in prevention of deep-vein thrombosis. Lancet. 1971;2(7726):669-671.
9. Crane C. Deep venous thrombosis and pulmonary embolism; experience with 391 patients treated with heparin and 126 patients treated by venous division, with a review of the literature. N Engl J Med. 1957;257(4):147-157.
10. Zurawska U, Parasuraman S, Goldhaber SZ. Prevention of pulmonary embolism in general surgery patients. Circulation. 2007;115(9):e 302-e307.
11. Agnelli G, Piovella F, Buoncristiani P, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med. 1998;339(2): 80-85.
12. Task Force on Pulmonary Embolism, European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism. Eur Heart J. 2000;21(16):1301-1336.
13. Frostick SP. Death after joint replacement. Haemostasis. 2000;30(suppl 2): 84-87.
14. Collins R, Scrimgeour A, Yusuf S, et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988;318(18):1162-1173.
15. Leizorovicz A, Haugh MC, Chapuis FR, et al. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ. 1992;305(6859):913-920.
16. Guidelines on diagnosis and management of acute pulmonary embolism. Task force on pulmonary embolism, European Society of Cardiology. Eur Heart J. 2000;21(16):1301-1336.
17. Goldhaber SZ, Turpie AG. Prevention of venous thromboembolism among hospitalized medical patients. Circulation. 2005;111(1):e1-e3.
18. Anderson FA. Venous thromboembolism in hospitalized patients-are we doing enough to prevent it? Commentary to the ENDORSE trial. Pol Arch Med Wewn. 2008;118(10):536-537.
19. Spencer FA, Emery C, Lessard D, et al. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen InternMed. 2006;21(7):722-727.
20. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the European society of cardiology (ESC). Eur Heart J. 2008;29(18):2276-2315.
21. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6)(suppl):381S-453S.
22. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3)(suppl):338S-400S.
23. Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg. 1988;208(2):227-240.
24. Nurmohamed MT, Rosendaal FR, Buller HR, et al. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a metaanalysis. Lancet. 1992;340(8812):152-156.
25. Kakkar VV, Cohen AT, Edmonson RA, et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group. Lancet. 1993;341(8840):259-265.
26. Jorgensen LN, Wille-Jorgensen P, Hauch O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg. 1993;80(6):689-704.
27. Thomas DP. Does low molecular weight heparin cause less bleeding? Thromb Haemost. 1997;78(6):1422-1425.
28. Koch A, Ziegler S, Breitschwerdt H, et al. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data. Thromb Res. 2001;102(4):295-309.
29. Haas S, Wolf H, Kakkar AK, et al. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin. Thromb Haemost. 2005;94(4):814-819.
30. Sullivan SD, Kahn SR, Davidson BL, et al. Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery. Pharmacoeconomics. 2003;21(7):477-496.
31. Avorn J, Winkelmayer WC. Comparing the costs, risks, and benefits of competing strategies for the primary prevention of venous thromboembolism. Circulation. 2004;110(24)(suppl 1):IV25-IV32.
32. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol. 2006;25(2):101-161.
33. Bergmann JF, Cohen AT, Tapson VF, et al. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE global survey. Thromb Haemost. 2010;103(4):736-748.
34. Kakkar AK, Cohen AT, Tapson VF, et al. Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients. Ann Surg. 2010;251(2):330-338.
35. US Department of Health and Human Services. The surgeon general's call to action to prevent deep venous thrombosis and pulmonary embolism. http://www.surgeongeneral.gov/topics/deepvein/calltoaction/call-toaction- on-dvt-2008.pdf. Published 2008. Accessed November 17, 2008.